NCT04738084 is a NA clinical trial of Meru Health Program in Depression, sponsored by Meru Health, Inc..

Who is sponsoring NCT04738084?

NCT04738084 is sponsored by Meru Health, Inc..

What drugs are being tested in NCT04738084?

Interventions in NCT04738084: Meru Health Program.

What condition does NCT04738084 study?

NCT04738084 studies Depression.

Is NCT04738084 still recruiting?

NCT04738084 is currently completed. Last updated 13 July 2023.

Last reviewed 2023-07-13 · How we verify

NCT04738084

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Meru Health Program Versus Waitlist Control for Adults With Depression

Completed NA Last updated 13 July 2023

What this trial tests

NA trial testing Meru Health Program in Depression in 100 participants. Completed in 30 December 2021.

Timeline

21 August 2020

Primary endpoint
15 April 2021

30 December 2021

Quick facts

Lead sponsor	Meru Health, Inc.
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	100
Start date	21 August 2020
Primary completion	15 April 2021
Estimated completion	30 December 2021
Sites	1 location across United States

Drugs / interventions tested

Meru Health Program

Conditions studied

Depression — all drugs for Depression →

Sponsor

Meru Health, Inc.

Who can join

18 and older, any sex, with Depression. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a randomized controlled trial (RCT) of the Meru Health Program (MHP) versus a waitlist (WL) control group, which will be offered access to the MHP after the waitlist period (12 weeks) is over, for adults with depression. The Meru Health Program (MHP) is a 12-week mobile mental health intervention delivered via Smartphone app that includes components of several evidence-based treatments (Cognitive Behavioral Therapy, Behavioral Activation Therapy, Mindfulness Meditation) and also several promising therapies (heart rate variability-biofeedback \[HRVB\], nutritional psychiatry, sleep training) that is overseen by a licensed clinical therapist.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Therapist-supported digital mental health intervention for depressive symptoms: A randomized clinical trial.
Forman-Hoffman VL, Sihvonen S, Wielgosz J, Kuhn E, et al · · 2024 · cited 5× · PMID 38211747 · DOI 10.1016/j.jad.2024.01.057
Therapist-Supported Digital Mental Health Intervention for Depressive Symptoms: A Randomized Clinical Trial
gould C. · · 2023 · DOI 10.31234/osf.io/6ka7s

Verify or expand the search:

Other trials of Meru Health Program

Trials testing the same drug.

NCT05615662 — Meru Health Program to Treat Depression in Primary Care · NA · withdrawn
NCT05588622 — Meru Health Program for Cancer Patients With Depression and Anxiety · NA · completed
NCT04744545 — RCT of Adjunctive Curcumin and the Meru Health Program · NA · completed

Other recruiting trials for Depression

Currently open trials in the same condition.

NCT07336238 — Group Retreat Psilocybin Therapy for the Treatment of Anxiety and Depression in Patients With Metastatic Solid Tumors or · Phase 2 · recruiting
NCT06906939 — A Randomized Pilot rTMS Trial for Knee Arthritis Pain and Depression · EARLY_PHASE1 · recruiting
NCT07517549 — Sexual Health Education During Pregnancy · NA · recruiting
NCT06408246 — ACE-D Aim 3 Clinical Cognitive Trial to Enhance Translation in Depression · Phase 2 · recruiting
NCT07449676 — Effects of an Innovative TCM-based Tui Jing Therapy on Psychological and Neurophysiological Functions in Depression · NA · recruiting

Other Meru Health, Inc. trials

Trials by the same sponsor.

NCT05615662 — Meru Health Program to Treat Depression in Primary Care · NA · withdrawn
NCT05588622 — Meru Health Program for Cancer Patients With Depression and Anxiety · NA · completed
NCT04744545 — RCT of Adjunctive Curcumin and the Meru Health Program · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04738084 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Meru Health, Inc.
Last refreshed: 13 July 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04738084.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing